J&J Seeks To Reclaim Schering's Arthritis Drug Rights
By Morgan Bettex ( May 28, 2009, 12:00 AM EDT) -- Johnson & Johnson has filed a demand for arbitration to sever an agreement between a subsidiary and Schering-Plough Corp. over the full rights to market and sell arthritis treatments Remicade and Simponi given the pending merger between Schering-Plough and Merck & Co....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.